Tie2-Cre, B6-TekCre Tg Tie2-Cre, B6-TekCre Tg 柳沢　正史 Carrier x Noncarrier [or Crossing to C57BL/6N(Crlj)] Carrier x Noncarrier [or Crossing to C57BL/6N(Crlj)] Tek-cre (Tie2-cre) transgenic mice. These mice express a cre recombinase gene under the control of the mouse Tek promoter. The University of Texas Southwestern Medical Center・柳沢正史先生。混合背景。 Developed by Masashi Yanagisawa, The University of Texas Southwestern Medical Center. Mixed background. Tek-cre (Tie2-cre) トランスジェニックマウス。マウスTekプロモーター制御下で、cre recombinase遺伝子を発現するトランスジェニックマウス。 <a href='https://brc.riken.jp/mus/pcr04495'>Genotyping protocol -PCR-</a> B (1-3 months) mouse Tie2 promoter, Phage P1 Cre, mouse metallothionein-1(MT-1) poly A signal, mouse Tie2 intron 1 enhancer Cre/loxP system B6.Cg-Tg(Tek-cre)1Ywa B6.Cg-Tg(Tek-cre)1Ywa true Masashi YANAGISAWA Necessary documents for ordering:<ol><li>Order form (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_4.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_b.docx">English</A>)</li><li>Category I MTA: MTA for distribution with RIKEN BRC (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_5.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_c.docx">English</A>)</li><li>Acceptance of responsibility for living modified organism (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_7.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_g.docx">English</A>)</li></ol><A HREF="https://www.md.tsukuba.ac.jp/basic-med/anatomy/embryology/index_e.html" target="_blank">Lab HP</A> B（1〜3か月） RBRC04495 条件を付加する。<br>研究成果の公表にあたって寄託者の指定する文献を引用する。Dev. Biol., 230, 230-242 (2001). <br>Depositor limits the use of the BIOLOGICAL RESOURCE to not-for-profit institutions. Depositor limits the use of the BIOLOGICAL RESOURCE to academic purposes. For-profit institutions and recipients who intend to use BIOLOGICAL RESOURCE for commercial research purposes shall acquire prior written consent from the Depositor. Recipient shall acquire prior written consent from the Depositor prior to filing an application for patent, or intellectual property or other rights based on the results of research using the BIOLOGICAL RESOURCE. In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. Dev. Biol., 230, 230-242 (2001). Depositor limits the use of the BIOLOGICAL RESOURCE to not-for-profit institutions. Depositor limits the use of the BIOLOGICAL RESOURCE to academic purposes. For-profit institutions and recipients who intend to use BIOLOGICAL RESOURCE for commercial research purposes shall acquire prior written consent from the Depositor. Recipient shall acquire prior written consent from the Depositor prior to filing an application for patent, or intellectual property or other rights based on the results of research using the BIOLOGICAL RESOURCE.